The following Life Sciences guidance note Produced in partnership with Elisabethann Wright, Marta Miglietti, Fabien Roy, Jane Summerfield, Julia Fraser and Richard Welfare of Hogan Lovells provides comprehensive and up to date legal information covering:
A worldwide problem, for developed and developing countries alike, is the trade of falsified medicinal products. The terms ‘falsified medicines’ and ‘counterfeit medicines’ are not interchangeable—falsified medicines refers to fake products designed to mimic actual medicines, whereas counterfeit medicines refers to products that infringe trademarks or other intellectual property rights.
In January 2013, Directive 2011/62/EC on the prevention of the entry into the legal supply chain of falsified medicinal products (Falsified Medicines Directive or FMD) became applicable. It was implemented in the UK by the Human Medicines (Amendment) Regulations 2013, SI 2013/1855.Directive 2011/62/EC, the Falsified Medicines DirectiveHuman Medicines (Amendment) Regulations 2013, SI 2013/1855
The FMD acknowledges an alarming increase of medicinal products detected in the EU which are falsified and reach patients through illegal means and via the legal supply chain alike. The FMD therefore amends Directive 2001/83/EC (consolidated version 16.11.2012), the Pharmaceutical Code, which is implemented in the UK by the Human Medicines Regulations 2012 (HMRs), SI 2012/1916, by introducing measures aimed at combatting falsified medicines.Human Medicines Regulations 2012, SI 2012/1916Recital 2 of Directive 2011/62/EC, the FMDDirective 2001/83/EC (consolidated version 16.11.2016), the Pharmaceutical Code
Such measures include:
rules on the controls and inspections of producers of active pharmaceutical substances
increased obligations for various actors in the supply chain, for example, brokers and record-keeping requirements for wholesale distributors
obligatory safety features, such as unique identifiers (UIs) and anti-tampering devices, on the outer packaging of the medicines to allow the verification of the authenticity of medicinal products subject to prescription
an EU-wide logo to identify legal online pharmacies, making it easier to distinguish between legal and illegal online
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234